The recent unemployment claims in the U.S. have hit another post-pandemic low. That’s bullish news for the economy. And it’s bullish news for quality penny stocks as well.
Let me clarify what I mean by penny stocks. These aren’t tiny stocks that trade for pennies like the junior mining stocks of the 1970s and 1980s. Or the odd pump-and-dump stocks that were all over the markets before 2008 washed them all away.
The penny stocks here are quality companies with real businesses and market caps that are in the 9- to 10-digit range. They’re fundamentally, low-priced, small-cap stocks.
And this is an ideal market for this sector. When growth accelerates, small companies can grow faster than larger stocks simply because it takes less growth to move them higher.
Before these stocks start making headlines, this is a good time learn about them and think about adding one or more to your portfolio.
ConforMIS (NASDAQ:CFMS) Hudson Technologies (NASDAQ:HDSN) HIVE Blockchain (NASDAQ:HVBT) Sify Technologies (NASDAQ:SIFY) CBAK Energy Technologies (NASDAQ:CBAT) Biolase (NASDAQ:BIOL) TransGlobeEnergy (NASDAQ:TGA)
Top 5 Penny Stocks For 2023: BioDelivery Sciences International Inc.(BDSI)
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, focuses on developing and commercializing products in the areas of pain management and oncology supportive care. The company uses its patented BioErodible MucoAdhesive (BEMA) and Bioral cochleate drug delivery technologies in the development of its products. The BEMA technology is a small erodible polymer film for application to the buccal mucosa; and the Bioral cochleate drug delivery technology encapsulates a selected drug or therapeutic in a cochleate cylinder. Its pain franchise consists of products utilizing the patented BEMA technology, including ONSOLIS, a fentanyl buccal soluble film for the management of pain in opioid tolerant adult patients with cancer; and BEMA Buprenorphine, which is in the development stage for the treatment of moderate to severe chronic pain, as well as for the treatment of opioid dependence. The company also engages in developing product candidates utilizing the B EMA technology for conditions, such as nausea/vomiting. BioDelivery Sciences International, Inc. was founded in 1997 and is headquartered in Raleigh, North Carolina.
Advisors’ Opinion:
- [By Motley Fool Transcribers]
Biodelivery Sciences International Inc (NASDAQ:BDSI)Q4 2018 Earnings Conference CallMarch 14, 2019, 4:30 p.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Joseph Griffin]
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Director Francis E. Odonnell, Jr. sold 8,000 shares of the firm’s stock in a transaction on Friday, February 1st. The stock was sold at an average price of $4.60, for a total value of $36,800.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
- [By Stephan Byrd]
Media headlines about BioDelivery Sciences International (NASDAQ:BDSI) have been trending somewhat positive recently, according to Accern Sentiment. The research firm identifies positive and negative media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. BioDelivery Sciences International earned a news sentiment score of 0.16 on Accern’s scale. Accern also assigned media headlines about the specialty pharmaceutical company an impact score of 46.960149735727 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Top 5 Penny Stocks For 2023: Investors Real Estate Trust(IRET)
Investors Real Estate Trust, a real estate investment trust (REIT), engages in the ownership and operation of income-producing real estate properties in the United States. It owns multi-family residential properties and commercial office, medical, industrial, and retail properties located primarily in the upper midwest states of Minnesota and North Dakota. As of April 30, 2008, the company operated a real estate portfolio of 72 multi-family residential; 65 office; 48 medical; 17 industrial; and 33 retail properties. Investors Real Estate Trust has elected to be taxed as a REIT under the Internal Revenue Code of 1986. As a REIT, the trust is not subject to federal corporate income taxes, if it distributes at least 90% of its taxable income to its shareholders. The company was founded in 1970 and is headquartered in Minot, North Dakota with additional offices in Minneapolis, Minnesota, and Omaha, Nebraska; and Kansas City, Kansas, and St. Louis, Missouri.
Advisors’ Opinion:
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Investors Real Estate Trust Reit (IRET)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Motley Fool Transcribing]
Investors Real Estate Trust (NYSE:IRET) Q1 2019 Earnings Conference CallSep. 11, 2018 10:00 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:
Operator
- [By Joseph Griffin]
Get a free copy of the Zacks research report on INVESTORS REAL ESTATE TRUST REIT Common Stock (IRET)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Motley Fool Staff]
Investors Real Estate Trust (NYSE:IRET) Q4 2018 Earnings Conference CallJun. 28, 2018 10:00 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:
Operator
Top 5 Penny Stocks For 2023: China Pharma Holdings Inc.(CPHI)
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical products primarily to hospitals and private retailers in the People?s Republic of China. Its products include Bumetanide to treat edema diseases; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of brain; Cerebroprotein Hydroloysate injection for the treatment of memory decline and attention deficit; Buflomedil Hydrochloride for blood vessel diseases; Propylgallate and Ozagrel Sodium for the treatment of cerebral thrombosis, coronary heart disease, and thrombus deep phlebitis; and Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and lipoprotein blood diseases. The company also offers Cefaclor Dispersible tablets for tympanitis, lower respiratory tract, urinary tract, and skin/skin tissue infection; Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Clarithromycin granules and capsules for nasoph arynx, respiratory tract, and skin tissue infections; Naproxen Sodium and Pseudophedrine Hydrochloride Sustained Release tablets to relieve cold, sinus, and flu symptoms; Cefalexin capsules for acute tonsillitis; and Anhydroandrographolide for ischemic heart, cerebrovascular, and lipoprotein blood diseases. In addition, it provides Hepatocyte growth-promoting factor to treat viral hepatitis symptoms; Tiopronin to treat acute chronic Hepatitis B and relieve liver injury; Omeprazole to treat gastroesophageal reflux disease; Granisetron Hydrochloride injection for nausea and vomiting; Vitamin B6, an vitamin supplement; Thymopolypetides injection for treating diseases and tumors of various cells with reduced immunological function; and Recombined Human Fibroblast Growth Factor for the production of cosmetics. The company distributes its products through independent regional distributors and sales representatives. China Pharma Holdings, Inc. is based in Haikou, the People?s Repub lic of China.
Advisors’ Opinion:
- [By Josh Enomoto]
Unfortunately, the company’s latest financial disclosure revealed that marketplace revenue “plunged 29% from a year earlier as users shopped elsewhere.” That’s a particularly tough blow as ContextLogic essentially received free marketing during the lockdowns. Apparently, that wasn’t enough although if you’re a cup-half-empty type, WISH stock is discounted 30% over the trailing month.
China Pharma Holdings (CPHI) Source: luchschenF / Shutterstock.com
Before I get into this next company on our list of Discord stocks, let me start with a firm disclosure: I am not going to touch China Pharma Holdings with a ten-foot pole. That’s not to say that I’m bearish on CPHI or anything of that nature. I just don’t have the nerves of steel required to put my money at risk.
- [By Logan Wallace]
These are some of the news headlines that may have impacted Accern Sentiment’s scoring:
Get Scynexis alerts:
Steady Activities: SCYNEXIS, Inc. (NASDAQ:SCYX), LPL Financial Holdings Inc. (NASDAQ:LPLA) (oracleexaminer.com) Do Analysts Think You Should Buy – SCYNEXIS Inc (NASDAQ: SCYX) (stockspen.com) Notable Runner: SCYNEXIS, Inc. (SCYX) (nasdaqplace.com) Most Active Stocks Now: SCYNEXIS, Inc. (NASDAQ:SCYX), China Pharma Holdings, Inc. (NYSE:CPHI), Kala … (journalfinance.net) Overview on price to free cash flow: SCYNEXIS, Inc. (NASDAQ:SCYX), InfuSystem Holdings Inc. (NYSE:INFU) (stocksnewspoint.com)
Several research analysts have recently issued reports on the company. Roth Capital assumed coverage on Scynexis in a research note on Tuesday, May 8th. They set a “buy” rating and a $6.00 price target for the company. Seaport Global Securities assumed coverage on Scynexis in a research note on Tuesday, April 10th. They set a “buy” rating and a $4.00 price target for the company. Zacks Investment Research raised Scynexis from a “hold” rating to a “buy” rating and set a $1.25 price target for the company in a research note on Tuesday, May 8th. HC Wainwright assumed coverage on Scynexis in a research note on Monday, May 7th. They set a “buy” rating and a $5.00 price target for the company. Finally, ValuEngine raised Scynexis from a “sell” rating to a “hold” rating in a research note on Wednesday, May 2nd. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. Scynexis currently has an average rating of “Buy” and an average target price of $4.45.
Top 5 Penny Stocks For 2023: Eagle Bulk Shipping Inc.(EGLE)
Eagle Bulk Shipping Inc. engages in the ocean transportation of bulk cargoes in the dry bulk industry. The company primarily transports iron ore, coal, grain, cement, and fertilizer along worldwide shipping routes. As of December 31, 2009, it owned and operated a fleet of 27 oceangoing vessels with a combined carrying capacity of 1,412,535 deadweight tons. The company was founded in 2005 and is headquartered in New York, New York.
Advisors’ Opinion:
- [By Rich Smith (TMFDitty)]
For another — and perhaps taking a cue from the first catalyst — investment bank H.C. Wainwright waded into the dry shipping waters Monday to deliver a series of buy recommendations for nearly every stock in the industry. Diana and Safe Bulkers both got buy ratings, for example, as did Genco Shipping (NYSE:GNK), Eagle Bulk (NASDAQ:EGLE), and Seanergy, too. Castor, though, did not.
- [By Motley Fool Transcribers]
Eagle Bulk Shipping Inc (NASDAQ:EGLE)Q4 2018 Earnings Conference CallMarch 06, 2019, 8:00 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Joseph Griffin]
Eagle Bulk Shipping Inc. (NASDAQ:EGLE) major shareholder Goldentree Asset Management Lp acquired 84,969 shares of the business’s stock in a transaction on Monday, February 11th. The shares were bought at an average cost of $4.02 per share, for a total transaction of $341,575.38. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
- [By Stephan Byrd]
Several brokerages have updated their recommendations and price targets on shares of Eagle Bulk Shipping (NASDAQ: EGLE) in the last few weeks:
7/2/2018 – Eagle Bulk Shipping was downgraded by analysts at ValuEngine from a “hold” rating to a “sell” rating. 6/28/2018 – Eagle Bulk Shipping was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating. 6/18/2018 – Eagle Bulk Shipping is now covered by analysts at Morgan Stanley. They set an “equal weight” rating and a $6.50 price target on the stock. 6/18/2018 – Eagle Bulk Shipping is now covered by analysts at DNB Markets. They set a “buy” rating on the stock. 6/12/2018 – Eagle Bulk Shipping was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating. 6/2/2018 – Eagle Bulk Shipping was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating. 6/2/2018 – Eagle Bulk Shipping was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating. 5/29/2018 – Eagle Bulk Shipping is now covered by analysts at Evercore ISI. They set an “outperform” rating and a $7.50 price target on the stock. 5/15/2018 – Eagle Bulk Shipping was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Eagle Bulk Shipping is the largest U.S. based owner of Handymax dry bulk vessels. Handymax dry bulk vessels range in size from 35,000 to 60,000 deadweight tons, or dwt, and transport a broad range of major and minor bulk cargoes, including iron ore, coal, grain, cement and fertilizer, along worldwide shipping routes. ” 5/9/2018 – Eagle Bulk Shipping had its “hold” rating reaffirmed by analysts at Maxim Group. They now have a $6.00 price target on the
Top 5 Penny Stocks For 2023: Luna Innovations Incorporated(LUNA)
Luna Innovations Incorporated engages in the research, development, and commercialization of technologies in the areas of sensing and instrumentation products, and health care products primarily in the United States. The company?s Product and Licensing segment offers test and measurement products to monitor the integrity of fiber optic network and sub-assemblies. This segment provides Optical Vector Analyzer platform, a device for single-measurement, all-parameter analysis of fiber optic components and assemblies up to 150 meters in length; Optical Backscatter Reflectometer, a sensitive diagnostic device, for data and telecommunications companies, and service providers who maintain their own fiber optic networks; and Phoenix laser, a MEMs-based external cavity laser, that offers low noise and precise tuning capability over the C-band. It also offers distributed sensing systems, which comprise multiple sensors whose input is integrated through a fiber optic network and soft ware to detect distributed strain, shape, and temperature; and tunable lasers. In addition, this segment provides health care products, including medical devices for minimally invasive diagnostics, surgery, and therapy; non-invasive monitoring and diagnosis medical devices consisting of emboli detection and classification QUANTIFIER, a non-invasive medical device, that uses quantitative ultrasound technology to count emboli in ex-vivo blood circuit; and nanomaterial-based medical products comprising Trimetasphere nanomaterials. The company?s Technology Development segment provides contract research services to universities, government entities, and corporations. Luna Innovations Incorporated offers its services to energy, telecommunications, life sciences, and defense industries .The company was incorporated in 1990 and is headquartered in Roanoke, Virginia.
Advisors’ Opinion:
- [By Max Byerly]
Luna Innovations Incorporated (NASDAQ:LUNA) rose 16.6% during trading on Monday . The company traded as high as $4.14 and last traded at $3.93. Approximately 651,876 shares changed hands during mid-day trading, an increase of 1,262% from the average daily volume of 47,854 shares. The stock had previously closed at $3.37.
- [By Shane Hupp]
Luna Coin (CURRENCY:LUNA) traded 5.2% higher against the dollar during the 24 hour period ending at 16:00 PM Eastern on September 26th. Luna Coin has a total market capitalization of $11,480.00 and approximately $13.00 worth of Luna Coin was traded on exchanges in the last day. One Luna Coin coin can now be bought for $0.0067 or 0.00000104 BTC on major exchanges including CoinExchange and YoBit. Over the last seven days, Luna Coin has traded 20.8% lower against the dollar.
- [By Ethan Ryder]
Luna Coin (CURRENCY:LUNA) traded up 0.8% against the dollar during the one day period ending at 14:00 PM Eastern on September 18th. One Luna Coin coin can now be bought for about $0.0086 or 0.00000135 BTC on exchanges including CoinExchange and YoBit. Luna Coin has a market cap of $14,603.00 and approximately $2.00 worth of Luna Coin was traded on exchanges in the last day. In the last seven days, Luna Coin has traded down 6.7% against the dollar.
